Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 1/2 2Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Inflammatory Bowel Diseases 1Diverticulitis 1Diverticular Diseases 1Colonic Neoplasms 1Agnosia 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Passive Cutaneous Anaphylaxis × Clear all
NCT01477190 2011-11-28

Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 1/2 Completed
40 enrolled
Gastrointestinal

Colonic Neoplasms, Diverticulitis, Inflammatory Bowel Diseases

NCT00747292 2008-09-05

Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery

Minimal Access Therapy Training Unit

Phase 1/2 Unknown
99 enrolled

Diverticular Diseases, Agnosia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡